• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inhalable exosomes to target cardiac repair.用于靶向心脏修复的可吸入外泌体。
Extracell Vesicles Circ Nucl Acids. 2025 Mar 25;6(1):180-182. doi: 10.20517/evcna.2024.81. eCollection 2025.
2
Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.可吸入干细胞外泌体促进心肌梗死后的心脏修复。
Circulation. 2024 Aug 27;150(9):710-723. doi: 10.1161/CIRCULATIONAHA.123.065005. Epub 2024 Aug 26.
3
Interleukin-10 Deficiency Alters Endothelial Progenitor Cell-Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment.白细胞介素-10 缺乏通过整合素连接激酶富集改变内皮祖细胞衍生的外泌体对心肌修复的修复作用。
Circ Res. 2020 Jan 31;126(3):315-329. doi: 10.1161/CIRCRESAHA.119.315829. Epub 2019 Dec 9.
4
A Minimally Invasive Exosome Spray Repairs Heart after Myocardial Infarction.微创外泌体喷雾修复心肌梗死后的心脏。
ACS Nano. 2021 Jul 27;15(7):11099-11111. doi: 10.1021/acsnano.1c00628. Epub 2021 Jun 21.
5
Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction.胚胎干细胞衍生的外泌体可促进内源性修复机制,并增强心肌梗死后的心脏功能。
Circ Res. 2015 Jun 19;117(1):52-64. doi: 10.1161/CIRCRESAHA.117.305990. Epub 2015 Apr 22.
6
Exosomes in Myocardial Repair: Advances and Challenges in the Development of Next-Generation Therapeutics.心肌修复中的细胞外囊泡:新一代治疗药物开发的进展与挑战。
Mol Ther. 2018 Jul 5;26(7):1635-1643. doi: 10.1016/j.ymthe.2018.04.024. Epub 2018 May 3.
7
Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide.使用心脏归巢肽靶向心肌梗死再生的外泌体。
Theranostics. 2018 Feb 14;8(7):1869-1878. doi: 10.7150/thno.20524. eCollection 2018.
8
Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction.间充质干细胞和心肌细胞来源的外泌体治疗心肌梗死的研究进展。
Cell Commun Signal. 2023 Aug 14;21(1):202. doi: 10.1186/s12964-023-01227-9.
9
Bispecific Antibody Inhalation Therapy for Redirecting Stem Cells from the Lungs to Repair Heart Injury.双特异性抗体吸入疗法:将肺部干细胞重定向以修复心脏损伤
Adv Sci (Weinh). 2020 Nov 19;8(1):2002127. doi: 10.1002/advs.202002127. eCollection 2020 Jan.
10
Novel Applications of Mesenchymal Stem Cell-derived Exosomes for Myocardial Infarction Therapeutics.间充质干细胞衍生的外泌体在心肌梗死治疗中的新应用。
Biomolecules. 2020 May 2;10(5):707. doi: 10.3390/biom10050707.

本文引用的文献

1
Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.可吸入干细胞外泌体促进心肌梗死后的心脏修复。
Circulation. 2024 Aug 27;150(9):710-723. doi: 10.1161/CIRCULATIONAHA.123.065005. Epub 2024 Aug 26.
2
Native and bioengineered extracellular vesicles for cardiovascular therapeutics.用于心血管治疗的天然和生物工程细胞外囊泡。
Nat Rev Cardiol. 2020 Nov;17(11):685-697. doi: 10.1038/s41569-020-0389-5. Epub 2020 Jun 1.
3
Extracellular Vesicles and the Application of System Biology and Computational Modeling in Cardiac Repair.细胞外囊泡与系统生物学和计算建模在心脏修复中的应用。
Circ Res. 2018 Jul 6;123(2):188-204. doi: 10.1161/CIRCRESAHA.117.311215.
4
Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs.诱导多能干细胞(iPSC)衍生的细胞外囊泡比 iPSC 更安全、更有效地用于心脏修复。
Circ Res. 2018 Jan 19;122(2):296-309. doi: 10.1161/CIRCRESAHA.117.311769. Epub 2017 Nov 8.
5
Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction.胚胎干细胞衍生的外泌体可促进内源性修复机制,并增强心肌梗死后的心脏功能。
Circ Res. 2015 Jun 19;117(1):52-64. doi: 10.1161/CIRCRESAHA.117.305990. Epub 2015 Apr 22.

用于靶向心脏修复的可吸入外泌体。

Inhalable exosomes to target cardiac repair.

作者信息

Magadum Ajit

机构信息

Aging and Cardiovascular Discovery Center (ACDC), Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.

Center for Regenerative Medicine and USF Health Heart Institute, Department of Internal Medicine, University of South Florida, Tampa, FL 33602, USA.

出版信息

Extracell Vesicles Circ Nucl Acids. 2025 Mar 25;6(1):180-182. doi: 10.20517/evcna.2024.81. eCollection 2025.

DOI:10.20517/evcna.2024.81
PMID:40206793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11977353/
Abstract

A recent study introduces Stem Cell-derived Exosome Nebulization Therapy (SCENT), a novel, non-invasive strategy that delivers lung spheroid cell-derived exosomes via inhalation to promote cardiac repair after myocardial infarction. This approach improves cardiac function, reduces injury, and demonstrates translational potential in both small and large animal models, offering a promising avenue for cell-free, inhalable regenerative therapies.

摘要

最近的一项研究引入了干细胞衍生外泌体雾化疗法(SCENT),这是一种新型的非侵入性策略,通过吸入递送肺球状体细胞衍生的外泌体,以促进心肌梗死后的心脏修复。这种方法可改善心脏功能,减少损伤,并在小型和大型动物模型中都显示出转化潜力,为无细胞、可吸入的再生疗法提供了一条有前景的途径。